Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis
- Author
- GOUZOULIS-MAYFRANK, Euphrosyne1 2 ; HEEKEREN, Karsten1 2 ; NEUKIRCH, Anna1 2 ; STOLL, Martina2 ; STOCK, Carsten2 ; DAUMANN, Joerg1 ; OBRADOVIC, Maja3 ; KOVAR, Karl-Artur3
[1] Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
[2] Department of Psychiatry and Psychotherapy, Medical Faculty of the University of Technology Aachen (RWTH), Aachen, Germany
[3] Institute of Pharmacy, University of Tübingen, Tübingen, Germany - Source
Neuropsychopharmacology (New York, NY). 2006, Vol 31, Num 2, pp 431-441, 11 p ; ref : 1 p.1/4
- CODEN
- NEROEW
- ISSN
- 0893-133X
- Scientific domain
- Neurology; Pharmacology drugs; Psychology, psychopathology, psychiatry
- Publisher
- Nature Publishing, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Inhibition of Return (IOR) NDMA antagonist S-ketamine dimethyltryptamine experimental psychosis orienting of attention
- Keyword (fr)
- Agoniste antagoniste Amine(diméthyl nitroso) Antagoniste Attention Homme Inhibition de retour Kétamine Modèle NMDA Psychose Substance toxicomanogène Phencyclidine dérivé Récepteur NMDA Récepteur glutamate
- Keyword (en)
- Agonist antagonist Antagonist Attention Human Inhibition of return Ketamine Models NMDA Psychosis Drug of abuse NMDA receptor Glutamate receptor
- Keyword (es)
- Agonista antagonista Antagonista Atención Hombre Inhibición de vuelta Ketamina Modelo NMDA Psicosis Sustancia toxicomanógena Receptor NMDA Receptor glutámato
- Classification
- Discipline
- Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17519368
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.npp.1300882 
https://dx.doi.org/10.1038/sj.npp.1300882
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.npp.1300882\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Neuropsychopharmacology (NY NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"431\";s:8:\"\u0000*\u0000epage\";s:3:\"441\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"GOUZOULIS-MAYFRANK\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Euphrosyne\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:17:\"HEEKEREN, Karsten\";i:1;s:14:\"NEUKIRCH, Anna\";i:2;s:14:\"STOLL, Martina\";i:3;s:14:\"STOCK, Carsten\";i:4;s:14:\"DAUMANN, Joerg\";i:5;s:15:\"OBRADOVIC, Maja\";i:6;s:17:\"KOVAR, Karl-Artur\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.npp.1300882\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Neuropsychopharmacology (NY NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"431\";s:8:\"\u0000*\u0000epage\";s:3:\"441\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"GOUZOULIS-MAYFRANK\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Euphrosyne\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:17:\"HEEKEREN, Karsten\";i:1;s:14:\"NEUKIRCH, Anna\";i:2;s:14:\"STOLL, Martina\";i:3;s:14:\"STOCK, Carsten\";i:4;s:14:\"DAUMANN, Joerg\";i:5;s:15:\"OBRADOVIC, Maja\";i:6;s:17:\"KOVAR, Karl-Artur\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.npp.1300882\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.npp.1300882\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Neuropsychopharmacology (NY NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"431\";s:8:\"\u0000*\u0000epage\";s:3:\"441\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"GOUZOULIS-MAYFRANK\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Euphrosyne\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:17:\"HEEKEREN, Karsten\";i:1;s:14:\"NEUKIRCH, Anna\";i:2;s:14:\"STOLL, Martina\";i:3;s:14:\"STOCK, Carsten\";i:4;s:14:\"DAUMANN, Joerg\";i:5;s:15:\"OBRADOVIC, Maja\";i:6;s:17:\"KOVAR, Karl-Artur\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.npp.1300882\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Neuropsychopharmacology (NY NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"431\";s:8:\"\u0000*\u0000epage\";s:3:\"441\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"GOUZOULIS-MAYFRANK\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Euphrosyne\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:17:\"HEEKEREN, Karsten\";i:1;s:14:\"NEUKIRCH, Anna\";i:2;s:14:\"STOLL, Martina\";i:3;s:14:\"STOCK, Carsten\";i:4;s:14:\"DAUMANN, Joerg\";i:5;s:15:\"OBRADOVIC, Maja\";i:6;s:17:\"KOVAR, Karl-Artur\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
